Mercia TV catches up with Locate Bio‘s CEO, John von Benecke in its Nottingham laboratory.

John talks through both its lead product LD Graft, a low dose, controlled release, rhBMP-2 bone graft, and CognitOss, an antibiotic loaded bone graft, with a dual and responsive release, for the treatment of osteomyelitis.

Read more on Mercia’s latest investment here